Innate Pharma Shares Are Trading Higher After the Company Announced Its TELLOMAK Phase 2 Trial of Lacutamab Demonstrated Significant Symptom Relief and Quality of Life Improvements.
Innate Pharma Shares Are Trading Higher After the Company Announced Its TELLOMAK Phase 2 Trial of Lacutamab Demonstrated Significant Symptom Relief and Quality of Life Improvements.
Innate pharma的股票在公司宣布其TELLOMAk 2期试验的Lacutamab显示出显著的症状缓解和生活质量改善后上涨。
Innate Pharma Shares Are Trading Higher After the Company Announced Its TELLOMAK Phase 2 Trial of Lacutamab Demonstrated Significant Symptom Relief and Quality of Life Improvements.
Innate pharma的股票在公司宣布其TELLOMAk 2期试验的Lacutamab显示出显著的症状缓解和生活质量改善后上涨。
译文内容由第三方软件翻译。
以上内容仅用作资讯或教育之目的，不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。
资讯热榜
更新时间